
Interventional @gwsmhs | Cardiovascular Imaging @NIH_NHLBI @MedStarHealth| Gen Cards via @StLukesCards @Templemedschool
Washington, DC
Joined August 2019
- Tweets631
- Following1.1K
- Followers621
- Likes5.5K
Presented at #TCT2026:
In patients with moderate aortic stenosis and high-risk features, the percentage who died or had a heart-failure event within 2 years was lower with transcatheter aortic-valve replacement than with surveillance (16.7% vs. 23.9%). Full PROGRESS trial results: nej.md/4eUv9kA
@crfheart
Shahrad Shadman, MD retweeted
In the NODULE-SHOCK trial, researchers evaluated phenotype-specific calcium modification in patients with and without severely calcified nodules using a new-generation coronary IVL catheter.
🔎 Explore the trial findings: bit.ly/4iRU2jh
#TCT2026 #JACCINT @crfheart
Shahrad Shadman, MD retweeted
Valve-in-Valve Transcatheter Aortic Valve Replacement Using the TRITON Technique: A Case Report jscai.org/article/S2772-9303… @MyJSCAI #TAVI #TAVR #Triton
Intra uterine surgery , please look at pulling the baby’s arm to put an IV!
@Dr_HaniNajm presented the video details of an extremely never before surgery in utero- but I was amazed by the fetus’s little arms!
#TCTMiddleEast2026 @TCT_ME_
#ESCCongress in Gregg Stone’s presentation just now there were tons of valuable data, but this one really stopped me! Can DCB be an alternative to DES? Workhorse to replace DES? The answer was a straight NO in red capital letters! Read below Selution!
EAPCI/EBC just dropped a landmark consensus in @EurHeartJ: IVUS or OCT should guide EVERY left main bifurcation stent, from lesion assessment → sizing → optimization.
No excuses. The data is in. Read more
Shahrad Shadman, MD retweeted
A dislodged TAVR valve (Transcatheter Aortic Valve Replacement valve embolization or migration) is a rare but serious complication where the implanted prosthetic valve moves from its intended position after deployment.
Cath lab plot twist of the year:
Referred for TAVR. Popped open the echo and…
that’s not severe AS. That’s a MASS the size of a small country sitting there like it pays rent.
Gently called referring MD: “So… funny story…” 😅
Shahrad Shadman, MD retweeted
SMART DECISION TRIAL
Beta-Blocker Discontinuation Post-MI
Can β-blockers be safely discontinued in stabilized post-MI patients?
🤔 A key clinical question in the era of revascularization and modern GDMT
♥️ Among stable patients who received beta-blocker beyond the 1st year after MI, discontinuation of beta-blocker therapy was noninferior to continuation
👎🏽13%💃🏻
Interesting to have HF as an endpoint since this wasn’t necessarily a population that have a lot of HF (excluded LVEF<40%)
#ACC26 #Cardiotwitter #LBCT #SecondaryPrevention @NEJM
📎 nejm.org/doi/full/10.1056/NE…
Great read!!!
Original Article: Intravascular Ultrasound–Guided or Angiography-Guided Complex High-Risk PCI (IVUS-CHIP trial) nejm.org/doi/full/10.1056/NE…
Editorial: IVUS — A Zigzag Path to Success nejm.org/doi/full/10.1056/NE…
#ACC26 | @ACCinTouch
2
288
Original Article: Intravascular Ultrasound–Guided or Angiography-Guided Complex High-Risk PCI (IVUS-CHIP trial) nejm.org/doi/full/10.1056/NE…
Editorial: IVUS — A Zigzag Path to Success nejm.org/doi/full/10.1056/NE…
#ACC26 | @ACCinTouch
Practice changing trial! 👏🏼👏🏼
Presented at #ACC26:
In the ALL-RISE trial, FFRangio (fractional flow reserve derived from angiography) was noninferior to pressure-wire–guided assessment in reducing risk among patients with intermediate coronary stenosis. Full trial results: nejm.org/doi/full/10.1056/NE…
Editorial: Toward Broader Adoption of Coronary Physiological Assessment nejm.org/doi/full/10.1056/NE…
@ACCinTouch
1
3
1,014
Shahrad Shadman, MD retweeted
Results of IVUS-CHIP and OPTIMAL: When compared with angiography-guided #PCI, IVUS-guided PCI was found to be not superior in patients with 👇
❇️ Complex coronary arteries ➡️ IVUS-CHIP
❇️ Unprotected LM-CAD ➡️ OPTIMAL
More on these #ACC26 LBCT trials: bit.ly/3Q7OZiK
Shahrad Shadman, MD retweeted
My thoughts on angio-based FFR are summarized in this NEJM editorial. Both FAST III and ALL-RISE - nearly identical in design and results - send a clear message that angio-based FFR is easy, safe, fast, and efficacious. Practice changing!
nejm.org/doi/pdf/10.1056/NEJ…
Presented at #ACC26:
Among patients with intermediate coronary lesions, angiography-guided revascularization was noninferior to pressure-wire–based guidance with respect to death, myocardial infarction, or revascularization. FAST III trial results: nejm.org/doi/full/10.1056/NE…
Editorial: Redefining Physiology in the Cardiac Catheterization Laboratory nejm.org/doi/full/10.1056/NE…
@ACCinTouch
Shahrad Shadman, MD retweeted
🚨 𝗕𝗥𝗘𝗔𝗞𝗜𝗡𝗚 from #ACC2026: Two major RCTs just challenged everything we thought about Impella pumps in cardiac care.
The results? Surprising.
The implications? Massive.
A thread on what every cardiologist needs to know 🧵👇
🧵So OPTIMAL just dropped at ACC.26, and I’ll be honest — it’s going to make a lot of interventionalists very UNCOMFORTABLE.
806 patients 😮. Unprotected left main PCI. Randomized to IVUS vs angiography guidance.
Result? No difference.🤯
🚨 There it is. The escape hatch.
Meanwhile, the January JACC meta-analysis of 13,751 patients says both IVUS and OCT are superior to angiography for MACE reduction in complex lesions including left main.
So which is it?
1
2
529
































